---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-002832"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:52:40.541917+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q3 revenue $26.3M, up 91% YoY; raises 2021 guidance to $99-101M

## Summary
- Revenue $26.3M (+91.3% YoY); product revenue $21.8M (+101.9% YoY).
- Net loss $30.5M ($0.65 loss per share); non-GAAP net loss $27.6M ($0.59).
- Gross margin improved to 11.2% from (37.3%) a year ago; product gross margin turned positive at 5.9%.
- FY2021 revenue guidance raised to $99-101M from prior $97-100M.
- Received favorable TPNIES decision for Tablo; cash balance $406.4M.

## SEC filing metadata
- accession: 0000950170-21-002832
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/0000950170-21-002832-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017021002832/om-20211103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-002832
- JSON: https://secwatch.observer/filing/0000950170-21-002832.json
- Plain text: https://secwatch.observer/filing/0000950170-21-002832.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.